Ironwood Pharmaceuticals

Yahoo Finance • 3 days ago

Wondering what's happening in today's after-hours session?

Discover the top movers in Friday's after-hours session and stay informed about the post-market dynamics. [postmarket] TODAY'S AFTER HOURS GAINERS TICKER CHANGE COMMENT DHAI [https://www.chartmill.com/stock/quote/DHAI/profile... Full story

Yahoo Finance • 11 days ago

Ironwood Pharmaceuticals Inc (NASDAQ:IRWD) Reports Strong Q2 2025 Earnings with 37.5% Revenue Beat and 250% EPS Surge

Ironwood Pharmaceuticals Inc (NASDAQ:IRWD [https://www.chartmill.com/stock/quote/IRWD]) reported its second-quarter 2025 results, delivering a significant earnings beat driven by strong performance of its flagship product LINZESS and progr... Full story

Yahoo Finance • last month

Ironwood Pharmaceuticals appoints KPMG as new auditor, dismisses EY

Ironwood Pharmaceuticals Inc. (NASDAQ:IRWD) announced that its Audit Committee has dismissed Ernst & Young LLP (EY) as its independent registered public accounting firm. The decision was made on July 3 after the committee solicited and re... Full story

Yahoo Finance • 4 months ago

Why Ironwood Pharmaceuticals Inc. (IRWD) Went Down On Thursday?

We recently published a list of 10 Stocks Fall Behind Amid Market Optimism. In this article, we are going to take a look at where Ironwood Pharmaceuticals Inc. (NASDAQ:IRWD) stands against other stocks that fall behind amid market optimism... Full story

Yahoo Finance • 2 years ago

Ironwood Pharmaceuticals Maintains FY 2023 Financial Guidance and Announces FY 2024 Financial Guidance

– Expects high-single digit percentage LINZESS® EUTRx prescription demand growth in 2024 – – Expects 2024 adjusted EBITDA of greater than $150 million – BOSTON, January 08, 2024--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (Nasdaq: I... Full story

Yahoo Finance • 2 years ago

Ironwood Announces the Completion of Squeeze-Out Merger With VectivBio

BOSTON, December 12, 2023--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. ("Ironwood") (Nasdaq: IRWD), a GI-focused healthcare company, today announced the successful completion of the squeeze-out merger under Swiss law (the "Squeeze-Out... Full story

Yahoo Finance • 3 years ago

15 Small Innovative Companies According to the Media

In this piece, we will take a look at the fifteen small innovative companies according to the media. For more small and innovative companies, head on over to 5 Small Innovative Companies According to the Media. Innovation is the bedrock o... Full story

Yahoo Finance • 3 years ago

12 Most Undervalued Pharma Stocks To Buy According To Hedge Funds

In this article, we discuss 12 most undervalued pharma stocks to buy according to hedge funds. If you want to see more stocks in this selection, check out 5 Most Undervalued Pharma Stocks To Buy According To Hedge Funds. Fitch Ratings has... Full story

Yahoo Finance • 3 years ago

Ironwood Pharmaceuticals Provides Update on FY 2022 Financial Guidance and Announces FY 2023 Financial Guidance

– sNDA submitted to U.S. FDA in December 2022 seeking approval of a new indication of LINZESS® (linaclotide) for functional constipation in children and adolescents 6 to 17 years of age – – Expects high single-digit LINZESS® EUTRx prescri... Full story

Yahoo Finance • 3 years ago

Ironwood Pharmaceuticals to Present at the 41st Annual J.P. Morgan Healthcare Conference

BOSTON, January 04, 2023--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a GI-focused healthcare company, today announced that Tom McCourt, CEO, will present at the 41st Annual J.P. Morgan Healthcare Conference on Wednesda... Full story

Yahoo Finance • 3 years ago

Keurig Dr Pepper, VICI Properties and ON Semiconductor Set to Join S&P 500; Others to Join S&P MidCap 400, and S&P SmallCap 600

NEW YORK, June 3, 2022 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 500, S&P MidCap 400 and S&P SmallCap 600 indices: VICI Properties Inc. (NYSE:VICI) will replace Cerner Corp. (NASD: CERN)... Full story